"Situé à l’extrémité de la presqu’île le Perharidy à Roscoff, le site bénéficie d’un environnement exceptionnel. Marqué par une histoire forte, c’est aujourd’hui un important site de Soins de Suite et de Réadaptation (SSR) à la pointe de la technologie : télémédecine, imprimante 3D, chambres domotisées, équipements sportifs, etc."

During the past decade, Centre de Perharidy conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 5 clinical trials were completed, i.e. on average, 22.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 3 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre de Perharidy" #1 sponsor was "University Hospital, Brest" with 9 trials, followed by "Vertex Pharmaceuticals Incorporated" with 5 trials sponsored, "Fondation Ildys" with 4 trials sponsored, "PTC Therapeutics" with 2 trials sponsored and "Corbus Pharmaceuticals Inc." with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre de Perharidy" #1 collaborator was "Lille Catholic University" with 3 trials as a collaborator, "Cystic Fibrosis Foundation" with 2 trials as a collaborator, "Vaincre la Mucoviscidose" with 2 trials as a collaborator, "Central Hospital, Nancy, France" with 1 trials as a collaborator and "Cyclacel Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Centre de Perharidy" are "Cystic Fibrosis" (17 trials), "Acute Respiratory Infection" (1 trials), "Autosomal Dominant Polycystic Kidney Disease (ADPKD)" (1 trials), "COVID-19" (1 trials) and "End Stage Renal Failure on Dialysis" (1 trials). Many other conditions were trialed in "Centre de Perharidy" in a lesser frequency.

Most popular intervention types in "Centre de Perharidy" are "Drug" (11 trials), "Other" (6 trials), "Device" (3 trials), "Biological" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "ELX/TEZ/IVA" (4 trials), "IVA" (4 trials), "Placebo (matched to ELX/TEZ/IVA)" (3 trials) and "Placebo (matched to IVA)" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centre de Perharidy" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Centre de Perharidy". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Centre de Perharidy, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre de Perharidy, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".